Related Experiment Video
Updated: Apr 16, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
A revised model of platelet aggregation
S Kulkarni1, S M Dopheide, C L Yap
1Australian Centre for Blood Diseases, Department of Medicine, Monash Medical School, Box Hill Hospital, Box Hill, Victoria 3128, Australia.
Platelet aggregation under flow is complex, involving continuous tethering and detachment. Platelet von Willebrand factor (vWf) initiates this process, followed by GPIbalpha binding and integrin alpha(IIb)beta(3) mediated arrest.
Area of Science:
- Hematology
- Biophysics
- Cardiovascular Biology
Background:
- Platelet aggregation is crucial for hemostasis and thrombosis.
- Understanding platelet dynamics under physiological flow is essential.
Purpose of the Study:
- To elucidate the intricate mechanism of platelet aggregation under physiological flow conditions.
- To investigate the roles of von Willebrand factor (vWf) and integrin alpha(IIb)beta(3) in flow-mediated platelet aggregation.
Main Methods:
- Utilized an in vitro flow-based platelet aggregation assay.
- Employed an in vivo rat thrombosis model.
- Studied platelets deficient in von Willebrand factor (vWf) or integrin alpha(IIb)beta(3).
Main Results:
- Observed continuous platelet tethering, translocation, and detachment under arterial and venous shear rates.
- Demonstrated that platelet vWf mediates tethering and translocation.
- Showed that integrin alpha(IIb)beta(3) is critical for irreversible platelet aggregation (cell arrest).
- Identified a three-step aggregation process: vWf exposure, reversible aggregation via GPIbalpha-vWf interaction, and irreversible aggregation via integrin alpha(IIb)beta(3).
Conclusions:
- Platelet aggregation under flow is a dynamic, multistep process.
- Platelet vWf plays a key initiating role in flow-induced platelet aggregation, challenging previous assumptions.
- The vWf-GPIbalpha interaction is vital for reversible aggregation, while integrin alpha(IIb)beta(3) ensures irreversible thrombus formation.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

